The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Skeletal-related events (SRE) and bone-targeted agents for metastatic prostate cancer: Are we changing outcomes?
Patricia Moretto
No relevant relationships to disclose
Brian Hutton
No relevant relationships to disclose
Iryna Kuchuk
No relevant relationships to disclose
Christina M. Canil
Consultant or Advisory Role - Amgen
Other Remuneration - Novartis
Terry L. Ng
No relevant relationships to disclose
Christina L. Addison
No relevant relationships to disclose
Mark J. Clemons
Honoraria - Amgen